Showing results (141-150 of 309) with videos related to
Sort By:
Pageof 31
Thrombosis and Haemostasis|June 12, 1999
The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of AnticoagulationP Lindmarker, S Schulman, M Sten-Linder, et al.American Heart Journal|April 1, 1987
Glucose tolerance and insulin response to glucose in nondiabetic young male survivors of myocardial infarctionA Hamsten, S Eféndic, G Walldius, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 1, 1996
In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathwayA Silveira, F Karpe, H Johnsson, et al.The American Journal of Cardiology|November 14, 1997
Effect of bezafibrate treatment over five years on coronary plaques causing 20% to 50% diameter narrowing (The Bezafibrate Coronary Atherosclerosis Intervention Trial [BECAIT])C G Ericsson, J Nilsson, L Grip, et al.European Heart Journal|July 1, 1984
Comparative study of echo- and angiocardiographically determined regional left ventricular wall motion in recent myocardial infarctionK Lindvall, A Hamsten, C Landou, et al.Atherosclerosis|May 6, 1998
Alimentary lipemia enhances the membrane expression of platelet P-selectin without affecting other markers of platelet activationA Bröijersén, F Karpe, A Hamsten, et al.The Journal of Clinical Investigation|March 1, 1993
Metabolism of triglyceride-rich lipoproteins during alimentary lipemiaF Karpe, G Steiner, T Olivecrona, et al.American Heart Journal|December 1, 1985
Shortened megakaryocyte-platelet regeneration time in young survivors of myocardial infarctionA Hamsten, J Svensson, G Walldius, et al.Lancet (London, England)|January 18, 1986
Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular eventsA Hamsten, R Norberg, M Björkholm, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 14, 1999
Effects of native, triglyceride-enriched, and oxidatively modified LDL on plasminogen activator inhibitor-1 expression in human endothelial cellsB A Allison, L Nilsson, F Karpe, et al.Pageof 31